Sungwoong Kim, Ph.D., is a research scientist at the Center for Toxicology and Human Health at UL Research Institutes’ Chemical Insights. He develops engineered organoid and tissue models that replicate human organ systems for toxicology studies, using three-dimensional environments and single-cell analysis to create alternatives to animal models. His research enables better evaluation of environmental exposures and supports human-centered public health strategies.

Kim earned his Ph.D. in Materials Science and Engineering from Cornell University, focusing on T and B cell regulation through engineered microenvironments and gene editing. He completed postdoctoral training at Georgia Tech’s CMaT and Emory University, where he developed scalable CAR-T cell manufacturing platforms and established assays for studying alloimmunity and antibody responses. In industry, he worked on lymphatic drug delivery systems at Sorrento Therapeutics, conducting preclinical studies and developing immunoassays for clinical application.

He has authored 12 peer-reviewed publications, holds two patents, and received the Immuno Delivery Focus Group Award from the Controlled Release Society.